Опыт лечения феринджектом пациенток с фибромиалгией и ферритином менее 60: перед этим их лечили пероральным железом, НО на фоне лечения их ферритин так и не повысился выше 60, их оценка по шкале Fibromyalgia Impact Questionnaire снизилась в 2.5 раза с 54 до 21:
This study was conducted on 90 female patients >18 years of age with ferritin <60 mcg/dL who presented to the Internal Medicine outpatient clinic in a large tertiary care hospital in Eskişehir, Turkey, with FM symptoms. Patients were selected from women who had previously received oral iron therapy for at least 3 months and whose ferritin could not be increased to >60 mcg/dL. Patients who met the 2010 criteria of the American College of Rheumatology for fibromyalgia were included in the study. Patient characteristics and laboratory parameters were recorded. The Fibromyalgia Impact Questionnaire (FIQ1, FIQ2) was applied and compared before and after IV iron treatment.
The mean age of the patients was 40±12 years (18-83). There was a significant change in the total score (FIQ1 mean: 54, FIQ2 mean: 21) and all parameters of the FIQ questionnaire after ferric carboxymaltose treatment (p<0.0001).
---
Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10375-10380.
Ferric carboxymaltose therapy reduces pain and improves the quality of life in female patients with fibromyalgia.
|